Statistics
Publications
2
Citations
22
H-Index
2
Active since
2024
Affiliations
Xue Liang is an author at Anhui Medical University specializing in cdk inhibitors, hematologic malignancy therapy, and acute myeloid leukemia therapy.
Publications per year
2024–2024
2
2
The roles and mechanisms of TGFB1 in acute myeloid leukemia chemoresistance
Xue Liang, J. Zhou, Cong Li et al. · Cellular Signalling · 2024 · 12 citations
Medicine, Cancer Biology, Oncology +12
The CDK4/6 Inhibitor Palbociclib Synergizes with ATRA to Induce Differentiation in AML
Linhui Hu, Qian Li, Jiyu Wang et al. · Molecular Cancer Therapeutics · 2024 · 10 citations
Medicine, Oncology, Pharmacology +17
1–2 of 2